AMAG AMAG Pharmaceuticals Inc.

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Latest News

1. 08 October 2019 AMAG Pharmaceuticals Announces Settlement Agreement with Caligan Partners LP

   WALTHAM, Mass., Oct. 08, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) ("AMAG") today announced that it has entered into a settlement agreement with Caligan Partners LP ("Caligan"). As part of this

2. 26 September 2019 Caligan Partners Issues Letter to AMAG Shareholders

   AMAG's Recent Public Letter Demonstrates Complete Disregard for Shareholders Current Board's Poor Decisions, Strategic Missteps and Lax Oversight Have Destroyed $1.1 Billion in Shareholder Value over Past Seven Years

3. 25 September 2019 AMAG Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference

   WALTHAM, Mass., Sept. 25, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) will participate in the Cantor Fitzgerald Global Healthcare Conference in New York on Thursday, October 3, 2019. Ted Myles,

4. 23 September 2019 AMAG Files Definitive Consent Revocation Statement and Sends Letter to Shareholders

   Details Caligan Partners' Reckless Business Ideas and Inexperienced Director Nominees Urges Shareholders to Sign and Return AMAG's GREEN Consent Revocation Card WALTHAM, Mass., Sept. 23, 2019 (GLOBE NEWSWIRE) -- AMAG

5. 16 September 2019 Caligan Partners Launches Consent Solicitation Process and Sends Letter to AMAG Shareholders

   Believes Removal of Four Incumbent Directors is Necessary to Stop Value Destruction at AMAG Caligan's Four Highly-Qualified Nominees Have the Experience and Skillsets Needed to Conduct Comprehensive Review of

6. 12 September 2019 AMAG Sends Letter to Shareholders

   WALTHAM, Mass., Sept. 12, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) ("AMAG" or the "Company") today issued the following letter, which will be mailed to its shareholders. AMAG's Board urges all

7. 05 September 2019 AMAG Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference

   WALTHAM, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) will participate in the Morgan Stanley Global Healthcare Conference on Tuesday, September 10, 2019. Bill Heiden, president and

8. 04 September 2019 AMAG Urges Stockholders to Take No Action on Caligan Partners' Consent Solicitation Materials

   WALTHAM, Mass., Sept. 04, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) ("AMAG" or the "Company") today responded to the preliminary consent solicitation filed by Caligan Partners ("Caligan") with

9. 27 August 2019 AMAG Pharmaceuticals Announces Commercial Availability of Vyleesi™ (Bremelanotide Injection)

   The First FDA-Approved As-Needed Treatment for Premenopausal Women Experiencing Low Sexual Desire and Associated Distress Now Available to Patients WALTHAM, Mass., Aug. 27, 2019 (GLOBE NEWSWIRE) -- AMAG